{"database": "lobbying", "table": "lobbying_activities", "rows": [[1991382, "f26ce0f8-49f7-42fb-8da2-e4e3ed9d466b", "Q2", "TARPLIN, DOWNS & YOUNG, LLC", 304736, "ABBVIE INC.", 2017, "second_quarter", "HCR", "PL114-255 - 21st Century Cures, implementation\nH.R. 1231/S. 456 - RACE for Children Act\nH.R  1628 - American Health Care Act of 2017\nS. 771 - Improving Access to Affordable Prescription Drugs Act\nS. 637 - Creating Transparency to Have Drug Rebates Unlocked Act of 2017\nStopping the Pharmaceutical Industry From Keeping Drugs Expensive Act of 2017\nS. 469 - Affordable and Safe Prescription Drug Importation act\nH.R. 749 - Lower Drug Costs Through Competition Act\nH.R. 2430 - FDA Reauthorization Act of 2017\nBetter Care Reconciliation Act of 2017\n\nno specific bill - FDA implementation issues, 340B, biosimilars, prescription drug user fee reauthorization, non-interference, patient assistance", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2017-07-18T12:15:48.970000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1991382"], "units": {}, "query_ms": 64.50723810121417, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}